98 related articles for article (PubMed ID: 12525867)
41. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
Gropp M; Reubinoff B
Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
43. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
44. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
45. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
46. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
[TBL] [Abstract][Full Text] [Related]
47. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
48. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
49. A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells.
Ren X; Katoh M; Hoshiya H; Kurimasa A; Inoue T; Ayabe F; Shibata K; Toguchida J; Oshimura M
Stem Cells; 2005; 23(10):1608-16. PubMed ID: 16141362
[TBL] [Abstract][Full Text] [Related]
50. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
51. Biosafety of herpesvirus vectors.
Gogev S; Schynts F; Meurens F; Bourgot I; Thiry E
Curr Gene Ther; 2003 Dec; 3(6):597-611. PubMed ID: 14683454
[TBL] [Abstract][Full Text] [Related]
52. Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence.
Calderwood M; White RE; Griffiths RA; Whitehouse A
J Gen Virol; 2005 Oct; 86(Pt 10):2703-2708. PubMed ID: 16186223
[TBL] [Abstract][Full Text] [Related]
53. Transduction of Herpesvirus saimiri-Transformed T Cells with Exogenous Genes of Interest.
Martínez-Barricarte R; de Jong SJ; Markle J; de Paus R; Boisson-Dupuis S; Bustamante J; van de Vosse E; Fleckenstein B; Casanova JL
Curr Protoc Immunol; 2016 Nov; 115():7.21C.1-7.21C.12. PubMed ID: 27801513
[TBL] [Abstract][Full Text] [Related]
54. Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines.
Simmer B; Alt M; Buckreus I; Berthold S; Fleckenstein B; Platzer E; Grassmann R
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1953-8. PubMed ID: 1651988
[TBL] [Abstract][Full Text] [Related]
55. Mutation of herpesvirus Saimiri ORF51 glycoprotein specifically targets infectivity to hepatocellular carcinoma cell lines.
Turrell SJ; Whitehouse A
J Biomed Biotechnol; 2011; 2011():785158. PubMed ID: 21197456
[TBL] [Abstract][Full Text] [Related]
56. Handling S/MAR vectors.
Hagedorn C; Baiker A; Postberg J; Ehrhardt A; Lipps HJ
Cold Spring Harb Protoc; 2012 Jun; 2012(6):657-63. PubMed ID: 22661441
[TBL] [Abstract][Full Text] [Related]
57. The pharmacology of gene therapy.
Minchin RF; Orr RJ; Cronin AS; Puls RL
Croat Med J; 1999 Sep; 40(3):381-91. PubMed ID: 10411966
[TBL] [Abstract][Full Text] [Related]
58. Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence.
Griffiths R; Harrison SM; Macnab S; Whitehouse A
J Gen Virol; 2008 Nov; 89(Pt 11):2843-2850. PubMed ID: 18931082
[TBL] [Abstract][Full Text] [Related]
59. Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line.
Grassmann R; Fleckenstein B
J Virol; 1989 Apr; 63(4):1818-21. PubMed ID: 2538660
[TBL] [Abstract][Full Text] [Related]
60. Self-Repairing Herpesvirus Saimiri Deletion Variants.
Heyn I; Bremer L; Zingler P; Fickenscher H
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
